{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:33:56Z","timestamp":1764714836108},"reference-count":271,"publisher":"Europa Digital & Publishing","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.4244\/eij-d-17-00646","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T08:27:55Z","timestamp":1521534475000},"page":"1904-1913","source":"Crossref","is-referenced-by-count":16,"title":["Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials"],"prefix":"10.4244","volume":"13","author":[{"given":"Si-Hyuck","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill D.","family":"Gogas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Hyun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Suck","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonjae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hwan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Won","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Sik","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Jin","family":"Youn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Ho","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"5ab0c561a5416-0","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2016.151"},{"key":"5ab0c561a5416-1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw343"},{"key":"5ab0c561a5416-2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.116.003785"},{"key":"5ab0c561a5416-3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr384"},{"key":"5ab0c561a5416-4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.11.060"},{"key":"5ab0c561a5416-5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61455-0"},{"key":"5ab0c561a5416-6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509038"},{"key":"5ab0c561a5416-7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00979-4"},{"key":"5ab0c561a5416-8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.03.038"},{"key":"5ab0c561a5416-9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.921528"},{"key":"5ab0c561a5416-10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60325-1"},{"key":"5ab0c561a5416-11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614954"},{"key":"5ab0c561a5416-12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr479"},{"key":"5ab0c561a5416-13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"5ab0c561a5416-14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.031843"},{"key":"5ab0c561a5416-15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.08.725"},{"key":"5ab0c561a5416-16","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY16M09_01"},{"key":"5ab0c561a5416-17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32050-5"},{"key":"5ab0c561a5416-18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.003210"},{"key":"5ab0c561a5416-19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.05.034"},{"key":"5ab0c561a5416-20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.10.903"},{"key":"5ab0c561a5416-21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.002427"},{"key":"5ab0c561a5416-22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002369"},{"key":"5ab0c561a5416-23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.08.853"},{"key":"5ab0c561a5416-24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990"},{"key":"5ab0c561a5416-25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.05.025"},{"key":"5ab0c561a5416-26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.019"},{"key":"5ab0c561a5416-27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.1106"},{"key":"5ab0c561a5416-28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx419"},{"key":"5ab0c561a5416-29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.009"},{"key":"5ab0c561a5416-30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht570"},{"key":"5ab0c561a5416-31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012843"},{"key":"5ab0c561a5416-32","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000156334.24955.B2"},{"key":"5ab0c561a5416-33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.029"},{"key":"5ab0c561a5416-34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14462-5"},{"key":"5ab0c561a5416-35","unstructured":"Schofer J, Breithardt G, Garcia E, Gershlick AH, Schl\u00fcter M, Wichter T and W. Wijns. The European multicenter, randomized, double-blind study of the Sirolimus-eluting stent in the treatment of patients with de novo coronary artery lesions (E-SIRIUS): 4-year clinical outcomes. Presented at the ESC 2006. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=3336 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035071"},{"key":"5ab0c561a5416-37","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000112572.57794.22"},{"key":"5ab0c561a5416-38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.077"},{"key":"5ab0c561a5416-39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.01.050"},{"key":"5ab0c561a5416-40","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000047700.58683.A1"},{"key":"5ab0c561a5416-41","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.03.030"},{"key":"5ab0c561a5416-42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.03.005"},{"key":"5ab0c561a5416-43","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000086926.62288.A6"},{"key":"5ab0c561a5416-44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.849877"},{"key":"5ab0c561a5416-45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.22.2727"},{"key":"5ab0c561a5416-46","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp224"},{"key":"5ab0c561a5416-47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032441"},{"key":"5ab0c561a5416-48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.10.003"},{"key":"5ab0c561a5416-49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67221-2"},{"key":"5ab0c561a5416-50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61660-2"},{"key":"5ab0c561a5416-51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.047"},{"key":"5ab0c561a5416-52","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn516"},{"key":"5ab0c561a5416-53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.562421"},{"key":"5ab0c561a5416-54","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm197"},{"key":"5ab0c561a5416-55","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-010-0278-8"},{"key":"5ab0c561a5416-56","first-page":"A33","article-title":"Four years follow-up of DIABETES trial.","volume":"53","author":"Jimenez-Quevedo P","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"5ab0c561a5416-57","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV9I3A54"},{"key":"5ab0c561a5416-58","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.2.165"},{"key":"5ab0c561a5416-59","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.22757"},{"key":"5ab0c561a5416-60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044372"},{"key":"5ab0c561a5416-61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051175"},{"key":"5ab0c561a5416-62","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn021"},{"key":"5ab0c561a5416-63","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.004762"},{"key":"5ab0c561a5416-65","first-page":"58","article-title":"A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial.","volume":"1","author":"Serruys PW","year":"2005","journal-title":"EuroIntervention"},{"key":"5ab0c561a5416-66","first-page":"266","article-title":"One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial).","volume":"1","author":"Tsuchida K","year":"2005","journal-title":"EuroIntervention"},{"key":"5ab0c561a5416-67","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV3I2A36"},{"key":"5ab0c561a5416-68","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/ccd.22428","article-title":"Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.","volume":"75","author":"Wiemer M","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"5ab0c561a5416-69","doi-asserted-by":"publisher","DOI":"10.1023\/B:CARD.0000033644.91126.f7"},{"key":"5ab0c561a5416-70","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.17.2109"},{"key":"5ab0c561a5416-71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.04.029"},{"key":"5ab0c561a5416-72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.08.009"},{"key":"5ab0c561a5416-73","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.552190"},{"key":"5ab0c561a5416-74","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm424"},{"key":"5ab0c561a5416-75","unstructured":"Dawkins KD. Long-Term Outcomes in Complex Patients Treated with the TAXUS Moderated Release Stent: TAXUS IV Three Year Clinical Results. Presented at the EuroPCR 2006. Available: [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-76","unstructured":"Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Thuesen L, Hauptmann KE, Marco J, Wijns W and Koglin J. Long-Term Outcomes in Complex Patients Treated with the TAXUS Moderated Release Stent: TAXUS IV 4-Year. Presented at the EuroPCR 2007. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=4464 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-77","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4244\/EIJV4I5A97","article-title":"TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions.","volume":"4(5)","author":"Grube E","year":"2009","journal-title":"EuroIntervention"},{"key":"5ab0c561a5416-78","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.591206"},{"key":"5ab0c561a5416-79","unstructured":"Meredith I. ENDEAVOR Clinical Program Update. Presented at the EuroPCR 2006. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=1953 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-80","unstructured":"Zeiher A. ENDEAVOR I & II Update. Presented at the EuroPCR 2007. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=4454 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-81","unstructured":"Fajadet J. ENDEAVOR Clinical Program Update. Presented at the EuroPCR 2008. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=5360 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-82","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV6I5A95"},{"key":"5ab0c561a5416-83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.08.035"},{"key":"5ab0c561a5416-84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.10.009"},{"key":"5ab0c561a5416-85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.12.014"},{"key":"5ab0c561a5416-86","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi721"},{"key":"5ab0c561a5416-87","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)01435-8"},{"key":"5ab0c561a5416-88","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-009-0305-7"},{"key":"5ab0c561a5416-89","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs036"},{"key":"5ab0c561a5416-90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062598"},{"key":"5ab0c561a5416-91","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV4I1A12"},{"key":"5ab0c561a5416-92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.11.003"},{"key":"5ab0c561a5416-93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.10.027"},{"key":"5ab0c561a5416-94","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.613588"},{"key":"5ab0c561a5416-95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.08.025"},{"key":"5ab0c561a5416-96","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I10A190"},{"key":"5ab0c561a5416-97","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV9I2A36"},{"key":"5ab0c561a5416-98","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.8.895"},{"key":"5ab0c561a5416-99","unstructured":"Morice MC, Serruys PW, Colombo A, Meier B, Tamburino C, Guagliumi G, Sousa E, Mendiz O and Grube E. Prospective Randomized Multicenter Head-to-Head Comparison of the Sirolimus-Eluting Stent and the Paclitaxel-Eluting Stent: 2-Year Outcome of the REALITY Trial. Presented at the ESC 2006. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=3389 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.09.021"},{"key":"5ab0c561a5416-101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.05.010"},{"key":"5ab0c561a5416-102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.01.056"},{"key":"5ab0c561a5416-103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062006"},{"key":"5ab0c561a5416-104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.10.007"},{"key":"5ab0c561a5416-105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.03.055"},{"key":"5ab0c561a5416-106","first-page":"536","article-title":"Are paclitaxel-eluting stents better in unprotected left main coronary artery disease? Three-year clinical and intravascular imaging results from a randomized study.","volume":"47","author":"Narbute I","year":"2011","journal-title":"Medicina (Kaunas)"},{"key":"5ab0c561a5416-107","first-page":"426","article-title":"Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.","volume":"2","author":"Chevalier B","year":"2007","journal-title":"EuroIntervention"},{"key":"5ab0c561a5416-108","doi-asserted-by":"crossref","unstructured":"Silber S. No Late and no Very Late Stent Thrombosis with a Drug-Eluting Stent of the Second Generation: 2 Years Results from the Randomized NOBORI-I trial. Presented at the AHA 2008. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=5903 [Accessed in Jan 2017]","DOI":"10.1161\/circ.118.suppl_18.S_747-b"},{"key":"5ab0c561a5416-109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.035"},{"key":"5ab0c561a5416-110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2011.12.010"},{"key":"5ab0c561a5416-111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.081"},{"key":"5ab0c561a5416-112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.09.046"},{"key":"5ab0c561a5416-113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.10.117"},{"key":"5ab0c561a5416-115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.056"},{"key":"5ab0c561a5416-116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.028"},{"key":"5ab0c561a5416-117","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.12.006"},{"key":"5ab0c561a5416-118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2008.00353.x"},{"key":"5ab0c561a5416-119","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.22369"},{"key":"5ab0c561a5416-120","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61244-1"},{"key":"5ab0c561a5416-121","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV6I8A162"},{"key":"5ab0c561a5416-122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.03.017"},{"key":"5ab0c561a5416-123","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I7A125"},{"key":"5ab0c561a5416-124","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61672-3"},{"key":"5ab0c561a5416-125","unstructured":"Serruys P. LEADERS 5-Year: A Prospective, Randomized Trial of Bioabsorbable Polymer-based Biolimus-Eluting vs. Sirolimus-Eluting Stents. Presented at the TCT 2012. Available: http:\/\/www.tctmd.com\/show.aspx?id=114397 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.04.011"},{"key":"5ab0c561a5416-127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.056"},{"key":"5ab0c561a5416-128","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.02.005"},{"key":"5ab0c561a5416-129","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I9A164"},{"key":"5ab0c561a5416-130","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.15.joc80026"},{"key":"5ab0c561a5416-131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.07.106"},{"key":"5ab0c561a5416-132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.03.023"},{"key":"5ab0c561a5416-134","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ccd.21510","article-title":"Prospective randomized comparison of sirolimus- versus paclitaxel-eluting stents for the treatment of acute ST-elevation myocardial infarction: pROSIT trial.","volume":"72","author":"Lee JH","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"5ab0c561a5416-135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2009.09.466"},{"key":"5ab0c561a5416-136","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.299.4.409","article-title":"Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.","volume":"299","author":"Galloe AM","year":"2008","journal-title":"JAMA"},{"key":"5ab0c561a5416-137","doi-asserted-by":"publisher","DOI":"10.3109\/14017431.2014.883461"},{"key":"5ab0c561a5416-138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.07.017"},{"key":"5ab0c561a5416-139","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.16.1903"},{"key":"5ab0c561a5416-140","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.803528"},{"key":"5ab0c561a5416-141","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2010.10.069"},{"key":"5ab0c561a5416-142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.07.009"},{"key":"5ab0c561a5416-143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.02.008"},{"key":"5ab0c561a5416-144","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810116"},{"key":"5ab0c561a5416-145","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60764-2"},{"key":"5ab0c561a5416-146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.01.035"},{"key":"5ab0c561a5416-147","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp044"},{"key":"5ab0c561a5416-148","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.020"},{"key":"5ab0c561a5416-149","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp352"},{"key":"5ab0c561a5416-150","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.06.027"},{"key":"5ab0c561a5416-151","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY14M11_02"},{"key":"5ab0c561a5416-152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.03.012"},{"key":"5ab0c561a5416-153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.03.016"},{"key":"5ab0c561a5416-154","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.11.029"},{"key":"5ab0c561a5416-155","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.10.003"},{"key":"5ab0c561a5416-156","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.108.831800.108.831800"},{"key":"5ab0c561a5416-157","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.10.002"},{"key":"5ab0c561a5416-158","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.22770"},{"key":"5ab0c561a5416-159","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV8I9A161"},{"key":"5ab0c561a5416-160","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.11.011"},{"key":"5ab0c561a5416-161","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009406"},{"key":"5ab0c561a5416-162","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)62127-9"},{"key":"5ab0c561a5416-163","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.02.023"},{"key":"5ab0c561a5416-164","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.03.028"},{"key":"5ab0c561a5416-165","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.08.067"},{"key":"5ab0c561a5416-166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.10.008"},{"key":"5ab0c561a5416-167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2010.07.008"},{"key":"5ab0c561a5416-168","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.12.123"},{"key":"5ab0c561a5416-169","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq199"},{"key":"5ab0c561a5416-170","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1004130"},{"key":"5ab0c561a5416-171","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60395-4"},{"key":"5ab0c561a5416-172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.12.036"},{"key":"5ab0c561a5416-173","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002230"},{"key":"5ab0c561a5416-174","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60208-5"},{"key":"5ab0c561a5416-175","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2012.04.008"},{"key":"5ab0c561a5416-176","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60405-0"},{"key":"5ab0c561a5416-177","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.07.025"},{"key":"5ab0c561a5416-178","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0910496"},{"key":"5ab0c561a5416-179","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.02.022"},{"key":"5ab0c561a5416-180","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.08.030"},{"key":"5ab0c561a5416-181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.03.086"},{"key":"5ab0c561a5416-182","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.24603"},{"key":"5ab0c561a5416-183","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.02.008"},{"key":"5ab0c561a5416-184","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.07.031"},{"key":"5ab0c561a5416-185","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-17-0677"},{"key":"5ab0c561a5416-186","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I8A148"},{"key":"5ab0c561a5416-187","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.026732"},{"key":"5ab0c561a5416-188","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.01.009"},{"key":"5ab0c561a5416-189","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.110.959924"},{"key":"5ab0c561a5416-190","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.02.016"},{"key":"5ab0c561a5416-191","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.12.011"},{"key":"5ab0c561a5416-192","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-1313"},{"key":"5ab0c561a5416-193","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.04.041"},{"key":"5ab0c561a5416-194","unstructured":"Branden BJVd, Koolen JJ, Henriques JP, Tijssen JG, Schaaf RJvd, Vermeersch PH and Suttorp MJ. A Randomized Comparison of Sirolimus-eluting Stent Implantation with Zotarolimus-eluting Stent Implantation for the Treatment of Total Coronary Occlusions: Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III trial). Presented at the ACC 2011. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=8659 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-195","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY14M08_07"},{"key":"5ab0c561a5416-196","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I12A224"},{"key":"5ab0c561a5416-197","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.10065"},{"key":"5ab0c561a5416-198","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.113.001440"},{"key":"5ab0c561a5416-199","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2011.11.009"},{"key":"5ab0c561a5416-200","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000000118"},{"key":"5ab0c561a5416-201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.12.016"},{"key":"5ab0c561a5416-202","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS"},{"key":"5ab0c561a5416-203","unstructured":"Meredith IT. Final five-year clinical outcomes in the EVOLVE trial: A randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. Presented at the EuroPCR 2016. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=4454 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-204","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV7I8A154"},{"key":"5ab0c561a5416-205","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61223-9"},{"key":"5ab0c561a5416-206","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.09.006"},{"key":"5ab0c561a5416-207","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00548-6"},{"key":"5ab0c561a5416-208","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.10.002"},{"key":"5ab0c561a5416-209","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61336-1"},{"key":"5ab0c561a5416-210","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu318"},{"key":"5ab0c561a5416-211","unstructured":"Camenzind E. Patient Related OuTcomes with Endeavor versus Cypher Stenting Trial: 5 Year Outcomes. Presented at the ESC 2014. Available: https:\/\/www.tctmd.com [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-212","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.104059"},{"key":"5ab0c561a5416-213","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.113.001322"},{"key":"5ab0c561a5416-214","doi-asserted-by":"publisher","DOI":"10.1159\/000315136"},{"key":"5ab0c561a5416-215","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.063644"},{"key":"5ab0c561a5416-216","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.07.004"},{"key":"5ab0c561a5416-217","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.02.014"},{"key":"5ab0c561a5416-218","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.11.051"},{"key":"5ab0c561a5416-219","doi-asserted-by":"publisher","DOI":"10.1007\/BF03091792"},{"key":"5ab0c561a5416-220","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.01.008"},{"key":"5ab0c561a5416-221","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.056"},{"key":"5ab0c561a5416-222","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.10.011"},{"key":"5ab0c561a5416-223","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY14M08_11"},{"key":"5ab0c561a5416-224","unstructured":"Birgelen Cv. TWENTE: A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients With Coronary Artery Disease: Five-Year Outcomes. Presented at the TCT 2015. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=10334 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.01.073"},{"key":"5ab0c561a5416-226","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY15M01_03"},{"key":"5ab0c561a5416-227","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064424"},{"key":"5ab0c561a5416-228","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61852-2"},{"key":"5ab0c561a5416-229","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV11I3A53"},{"key":"5ab0c561a5416-230","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.220"},{"key":"5ab0c561a5416-231","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.04.045"},{"key":"5ab0c561a5416-232","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.3584"},{"key":"5ab0c561a5416-233","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.002817"},{"key":"5ab0c561a5416-234","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2013.28.11.1609"},{"key":"5ab0c561a5416-235","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.03.001"},{"key":"5ab0c561a5416-236","first-page":"74","article-title":"Resolute China randomized controlled trial: Two-year results of resolute zotarolimus eluting stent versustaxusliberte paclitaxel eluting stent.","volume":"129","author":"Xu B","year":"2014","journal-title":"Cardiology (Switzerland)"},{"key":"5ab0c561a5416-237","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61962-X"},{"key":"5ab0c561a5416-238","doi-asserted-by":"crossref","unstructured":"Christiansen EH, Jensen LO, Thayssen P, Tilsted H-H, Krusell L, Kaltoft A, Maeng M, Ravkilde J and Lassen JF. Very Late Stent Thrombosis after Revascularization with Biolimus-Eluting Biodegradable Polymer-Coated Nobori Stent versus Durable Polymer-Coated Sirolimus-Eluting Stents from the SORT OUT V Trial. Presented at the TCT 2014. Available: https:\/\/www.tctmd.com\/slide\/tct-643-very-late-stent-thrombosis-after-revascularization-biolimus-eluting-biodegradable [Accessed in Jan 2017]","DOI":"10.1016\/j.jacc.2014.07.711"},{"key":"5ab0c561a5416-239","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61038-2"},{"key":"5ab0c561a5416-240","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003255"},{"key":"5ab0c561a5416-241","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62037-1"},{"key":"5ab0c561a5416-242","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-16-00571"},{"key":"5ab0c561a5416-243","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.03.028"},{"key":"5ab0c561a5416-244","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.09.008"},{"key":"5ab0c561a5416-245","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.02.016"},{"key":"5ab0c561a5416-246","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.08.123"},{"key":"5ab0c561a5416-248","doi-asserted-by":"publisher","DOI":"10.4244\/EIJY16M08_01"},{"key":"5ab0c561a5416-250","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-17-00873"},{"key":"5ab0c561a5416-251","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.07.013"},{"key":"5ab0c561a5416-253","unstructured":"Ellis SG, Kereiakes DJ and Stone GW. Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results. Presented at the ACC 2017. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=4454 [Accessed in Aug 2017]"},{"key":"5ab0c561a5416-254","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.010"},{"key":"5ab0c561a5416-255","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.09.054"},{"key":"5ab0c561a5416-256","unstructured":"Gao R. ABSORB China: Two-Year Clinical Results in Patients with Coronary Artery Disease Randomized to the Absorb Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stents. Presented at the TCT 2016. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=10334 [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-257","doi-asserted-by":"crossref","unstructured":"Gao R. Randomized comparison of everolimus-eluting bioresorbable vascular scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: 3-year clinical outcomes from ABSORB China. Presented at the EuroPCR 2017. Available: https:\/\/www.tctmd.com\/slide\/randomized-comparison-everolimus-eluting-bioresorbable-vascular-scaffolds-vs-everolimus [Accessed in Aug 2017]","DOI":"10.1016\/j.jacc.2018.08.1451"},{"key":"5ab0c561a5416-258","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv435"},{"key":"5ab0c561a5416-260","unstructured":"Kozuma K, Tanabe K and Kimura T. ABSORB Japan: 3-year Clinical and Angiographic Resultsof a Randomizedtrial Evaluating the Absorb Bioresorbable Vascular Scaffoldvs. Metallic Drug-eluting Stent in de novo Native Coronary Artery Lesions. Presented at the EuroPCR 2017. Available: https:\/\/www.tctmd.com\/slide\/absorb-japan-results-3-year-clinical-and-angiographic-results [Accessed in Aug 2017]"},{"key":"5ab0c561a5416-261"},{"key":"5ab0c561a5416-262","unstructured":"Sabat\u00e9 M. BRS in STEMI: Rationale, Registry outcomes and Trofi II 2-year results. Presented at the TCT 2016. Available: http:\/\/www.tctmd.com\/ [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-263","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013520"},{"key":"5ab0c561a5416-264","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001441"},{"key":"5ab0c561a5416-265","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.584"},{"key":"5ab0c561a5416-266","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-9"},{"key":"5ab0c561a5416-267","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.017"},{"key":"5ab0c561a5416-268","unstructured":"Puricel S. Comparison of Everolimus- and Biolimus-Eluting Coronary Stents With Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-year Outcomes of the EVERBIO II Trial. Presented at the TCT 2015. Available: http:\/\/www.tctmd.com\/ [Accessed in Jan 2017]"},{"key":"5ab0c561a5416-269","doi-asserted-by":"crossref","unstructured":"Kereiakes DJ. Late Clinical Outcomes after Bioresorbable or Permanent Polymer Everolimus-Eluting Stents: 2-Year Results from the EVOLVE II Randomized Trial. Presented at ACC 2016. Available: http:\/\/www.crtonline.org\/ [Accessed in Jan 2017]","DOI":"10.1016\/S0735-1097(16)30018-3"},{"key":"5ab0c561a5416-270","unstructured":"Kereiakes DJ. EVOLVE II 3-year data. Presented at the ACC 2017. Available: http:\/\/www.crtonline.org\/flash.aspx?PAGE_ID=4454 [Accessed in Aug 2017]"},{"key":"5ab0c561a5416-271","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61794-3"},{"key":"5ab0c561a5416-272","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.11.007"},{"key":"5ab0c561a5416-273","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.05.009"},{"key":"5ab0c561a5416-274","unstructured":"Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell L, Tilsted H-H, Junker A, Terkelsen CJ, Veien KT, Kaltoft A, Villadsen AB, Aaroe J, Berencsi K, Jensen SE, Hansen KN, Kristensen SD, Madsen M, B\u00f8tker HE, Hansen HS, Raungaard B, Lassen JF and Christiansen EH. Randomized comparison of a sirolimuseluting stent with a biolimus-eluting stent in patients treated with PCI: the SORT OUT VII trial. Presented in EuroPCR 2015."},{"key":"5ab0c561a5416-275","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.587"},{"key":"5ab0c561a5416-276","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510188"},{"key":"5ab0c561a5416-277","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.593"}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T04:24:45Z","timestamp":1719894285000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/131st_issue\/311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":271,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["EIJ-D-17-00646"],"URL":"https:\/\/doi.org\/10.4244\/eij-d-17-00646","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}